Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Nektar Therapeutics
NKTR:NASDAQ
Streetwise Company Fact Sheet
2024/4/17 20:27:34
(NKTR:NASDAQ)
Analyst coverage
J.P. Morgan
—
Jessica Fye
William Blair
—
Andy Hsieh
Oppenheimer & Co.
—
Jay Olson
Goldman Sachs
—
Chris Shibutani
Jefferies & Co.
—
Roger Song
Newsletter coverage
Ron Struthers
—
Struthers Resource Stock Report
Streetwise Reports Articles
04/15/2024 - View Article
03/27/2024 - View Article
02/12/2024 - View Article
Streetwise - Nektar Therapeutics Ownership Overview*
Nektar Therapeutics
(NKTR:NASDAQ)
*
Share Structure as of 3/27/2024